Status:
COMPLETED
An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
Lead Sponsor:
Hoffmann-La Roche
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
This multicenter, retrospective, observational study will evaluate the therapeutic effectiveness of a strategy of induction with Fuzeon (enfuvirtide) within an optimized regimen of antiretroviral drug...
Eligibility Criteria
Inclusion
- Adult patients, \>/= 18 years of age
- HIV-1+ infection
- Patients with a viral load \> 50 copies/ml who have received induction treatment with Fuzeon in combination with antiretroviral treatment
- Naïve for Fuzeon at initiation of induction treatment
- Antiretroviral treatment of at least 12 months duration
Exclusion
- Patients who did not receive Fuzeon treatment
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01902615
Start Date
January 1 2001
End Date
March 1 2008
Last Update
November 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barcelona, Barcelona, Spain, 08901